ImmunityBio, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−2.80%
vs ±10.2% implied · ×0.28
shaded = implied · ▲▼ = realized
Fund move
Fund move
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $298.4M | 14.99% | +29.37% | |
| 2 | State StreetState Streetindex-like | $187.3M | 9.41% | +20.84% | |
| 3 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $156.4M | 7.86% | +9.44% | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $137.4M | 6.90% | +3.73% | |
| 5 | D. E. ShawD. E. Shaw | $101.1M | 5.08% | −8.12% | |
| 6 | Two Sigma InvestmentsTwo Sigma | $97.2M | 4.88% | +153.04% | |
| 7 | Geode Capital ManagementGeodeindex-like | $86.2M | 4.33% | +22.61% | |
| 8 | Susquehanna International GroupSusquehanna International | $73.3M | 3.68% | −3.73% | |
| 9 | Citadel AdvisorsCitadel | $49.7M | 2.50% | +10.49% | |
| 10 | Millennium ManagementMillennium | $48.9M | 2.45% | +286.40% | |
| 11 | LMR PartnersLMR Partners | $37.2M | 1.87% | −2.16% | |
| 12 | Northern TrustNorthern Trustindex-like | $31.2M | 1.57% | +42.34% | |
| 13 | Morgan StanleyMorgan Stanley | $30.1M | 1.51% | −14.59% | |
| 14 | Goldman Sachs GroupGoldman Sachs | $28.3M | 1.42% | −0.09% | |
| 15 | UBS GroupUBS | $28.0M | 1.41% | +8.52% | |
| 16 | Great Point PartnersGreat Point Partners | $26.3M | 1.32% | 0.00% | |
| 17 | Charles Schwab Investment ManagementCharles Schwabindex-like | $25.3M | 1.27% | +16.57% | |
| 18 | Woodline PartnersWoodline Partners | $21.9M | 1.10% | −27.47% | |
| 19 | SEB Asset ManagementSEB | $21.4M | 1.08% | 0.00% | |
| 20 | Jane Street GroupJane Street | $21.1M | 1.06% | +2.50% | |
| 21 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $21.1M | 1.06% | new | |
| 22 | Bank of AmericaBank of America | $19.1M | 0.96% | −10.76% | |
| 23 | Voloridge Investment ManagementVoloridge | $15.1M | 0.76% | −41.18% | |
| 24 | Federated InvestorsFederated Investors | $15.0M | 0.75% | +23.55% | |
| 25 | Royal Bank of CanadaRoyal Bank of Canada | $13.5M | 0.68% | +3.81% |
409 managers report $2.0B of ImmunityBio on form 13F for the quarter ended Jun 30 '26. 26 of them hold 80% of it; BlackRock is largest at 14.99%.
ImmunityBio, Inc.
8.27
Expected move
Inputs8Q avg ±8.7%·×0.53·cheap
straddle ±11.8%
spot 8.29exp Nov 6ATM strike 8.5ATM straddle 1.15IV 123%